Aspiriant Risk-Managed Taxable Bond holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Aspiriant Risk-Managed Taxable Bond Fund RMTBX
- NAV / 1-Day Return $8.35 / +0.72 %
- Fund Size $411.2M
- Adjusted Expense Ratio 1.110%
- Net Expense Ratio 0.260%
- Fee Level: Distribution High
- Share Class Type No Load
- Morningstar Category Intermediate Core-Plus Bond
- Fixed-Income Style Box (Funds) —
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 4.77%
- Average Effective Duration 6.39 yrs
Morningstar’s Analysis RMTBX
Will RMTBX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 94.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Vanguard Total Bond Market Index I | 25.50 | 102M | — |
PIMCO Income Instl | 16.58 | 66M | — |
DoubleLine Total Return Bond I | 15.02 | 60M | — |
TCW MetWest Total Return Bd Plan | 9.64 | 39M | — |
River Canyon Total Return Bond Instl | 8.65 | 35M | — |
Vanguard Long-Term Treasury ETF | 7.11 | 28M | — |
GMO Emerging Country Debt VI | 5.28 | 21M | — |
JPMorgan Prime Money Market Inst | 5.12 | 21M | Cash and Equivalents |
TPG Twin Brook Capital Income D | 4.08 | 16M | — |
AG Direct Lending IV A | 1.58 | 6M | — |